When will we be able to start applying age-reversal gene therapy to humans? David Sinclair, Harvard’s David Sinclair explains
In just a minute 27 seconds, we learn what is happening, from the eye regeneration of mice to the monkey trials that will begin later this year to human trials in 2023 and a full body by a decade.
David Sinclair, a Harvard Medical School professor and world-leading biologist who wrote the New York Times bestseller @Lifespan, is a leading expert in biology.
His research on how to slow the aging process and why we age has made a significant contribution to the advancement of longevity science. David’s discoveries have been published by the most prestigious scientific journals. He founded many biotech firms, such as Life Biosciences MetroBiotech and InsideTracker.
David has won more than 25 awards for his research. In 2014, he was named one of TIME Magazine’s \”100 Most Influential People\” and in 2018, he was listed as \”50 Most Important People in Healthcare\”.
David and his co-workers have published an extraordinary paper in Nature with their epigenetic therapy which has restored the vision of mice. This paper was the most-accessed article in the last 12 months.
Join our Longevity ambassador list if you enjoyed this clip. Each month, Sourav and Sergey Young, the co-hosts, sit down with healthcare and longevity experts to discuss the latest in science, technology, and investing.
Sign up here: https://sergeyyoung.com/ama-list.
Follow me on Instagram: https://www.instagram.com/sergeyyoung200/
Source:
